Detection and quantitation of Kaposi's sarcoma-associated herpesvirus (KSHV) by a single competitive-quantitative polymerase chain reaction

Journal of Virological Methods

Volumn 107, Issue 2, 2003, Pages 261-267

  Curreli, Francesca ^a,b   Robles, Monica A ^a   Friedman Kien, Alvin E ^a   Flore, Ornella ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Competitor; KSHV; PCR; Viral load

Indexed keywords

DNA FRAGMENT; PRIMER DNA; VIRUS DNA;

ACCURACY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; LYMPHOMA; NONHUMAN; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN BIOPSY; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

BIOPSY; DNA, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; VIRAL LOAD;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 0037291535     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(02)00254-9     Document Type: Article

References (30)

1. Arvanitakis L., Mesri E.A., Nador R.G., Said J.W., Asch A.S., Knowles D.M., Cesarman E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 88:(7):1996;2648-2654.
2. Ballestas M.E., Chatis P.A., Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 284:(5414):1999;641-644.
3. Ballestas M.E., Kaye K.M. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75:(7):2001;3250-3258.
4. Boivin G., Gaudreau A., Toma E., Lalonde R., Routy J.P., Murray G., Handfield J., Bergeron M.G. Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Antimicrob. Agents Chemother. 43:(2):1999;377-380.
5. Boshoff C., Whitby D., Hatziloannou T., Fisher C., Van der Walt J., Hatzakis A., Weiss R., Schulz T. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet. 345:1995;1043-1044.
6. Campbell T.B., Fitzpatrick L., MaWhinney S., Zhang X., Schooley R.T. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection. J. Acquired Immune Defic. Syndr. 22:(4):1999;333-340.
7. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's Sarcoma-associated Herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. New Engl. J. Med. 332:1995;1186-1191.
8. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
9. Chang Y.A., Ziegler J., Wabinga H., Katangole-Mbidde E., Boshoff C., Schulz T., Whitby D., Maddalena D., Jaffe H.W., Weiss R.A., Moore P.S., Mugerwa J.W., Katabira E., Mwidu S., Beral V., Newton R., Parkin M., DeCock K. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch. Intern. Med. 156:(2):1996;202-204.
10. Dupin N., Grandaman M., Calvez V., Gorin I., Aubin T., Havard S., Lamy F., Leibowitch M., Hauraux J., Escande J., Augut H. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet. 345:1995;761-762.
11. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., van Marck E., Salmon D., Gorin I., Escande J.P., Weiss R.A., Alitalo K., Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA. 96:(8):1999;4546-4551.
12. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:(10):1996;986-994.
13. Lallemand F., Desire N., Rozenbaum W., Nicolas J.C., Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J. Clin. Microbiol. 38:(4):2000;1404-1408.
14. Leao J.C., Kumar N., McLean K.A., Porter S.R., Scully C.M., Swan A.V., Teo C.G. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients. J. Med. Virol. 62:(4):2000;416-420.
15. Lebbe C., Blum L., Pellet C., Blanchard G., Verola O., Morel P., Danne O., Calvo F. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. Aids. 12:(7):1998;F45-F49.
16. Lock M.J., Griffiths P.D., Emery V.C. Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8. J. Virol. Methods. 64:(1):1997;19-26.
17. Menezes J., Leibold W., Klein G., Clements G. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJAB) from an exceptional EBV-genome negative African Burkitt's lymphoma. Biomedicine. 22:1975;276-280.
18. Moore P.S., Chang Y. Detection of Herpesvirus-like DNA sequences in Kaposi's Sarcoma in patients with and those without HIV infection. New Engl. J. Med. 332:1995;1181-1185.
19. Nador R.G., Cesarman E., Knowles D.M., Said J.W. Herpes-like DNA sequences in a body cavity-based lymphoma in an HIV-negative patient. New Engl. J. Med. 333:(14):1995;943.
20. Nador R.G., Cesarman E., Chadburn A., Dawson D.B., Ansari M.Q., Said J., Knowles D.M. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 88:(2):1996;645-656.
21. Quinlivan E.B., Zhang C., Stewart P.W., Komoltri C., Davis M.G., Wehbie R.S. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J. Infect. Dis. 185:(12):2002;1736-1744.
22. Rainbow L., Platt G.M., Simpson G.R., Sarid R., Gao S.J., Stoiber H., Herrington C.S., Moore P.S., Schulz T.F. The 222- to 234-kDa latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 71:(8):1997;5915-5921.
23. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:(3):1996;342-346.
24. Renne R., Blackbourn D., Whitby D., Levy J., Ganem D. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 72:(6):1998;5182-5188.
25. Sadler R., Wu L., Forghani B., Renne R., Zhong W., Herndier B., Ganem D. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:(7):1999;5722-5730.
26. Schalling M., Ekman M., Kaaya E.E., Linde A., Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat. Med. 1:1995;707-708.
27. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., D'Agay M.F., Clauvel J.P., Raphael M., Degos L., Sigaux F. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 86:1995;1276-1280.
28. Tedeschi R., Enbom M., Bidoli E., Linde A., De Paoli P., Dillner J. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J. Clin. Microbiol. 39:(12):2001;4269-4273.
29. White I.E., Campbell T.B. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J. Clin. Microbiol. 38:(5):2000;1992-1995.
30. Zhang Y.J., Deng J.H., Rabkin C., Gao S.J. Hot-spot variations of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen and application in genotyping by PCR-RFLP. J. Gen. Virol. 81:(Pt 8):2000;2049-2058.